To speed breakthroughs that lead to new and improved treatments, and ultimately a cure, for Parkinson's disease by funding research, building partnerships and empowering the patient community.
The Michael J Fox Foundation for Parkinson's Research put $21,012,000 behind Parkinson's research at Parkinson's Foundation in 2025, and its giving pattern shows a large-scale research funder that backs both institutions and companies working across the disease pipeline. Recent awards also include multi-million-dollar support for Greenphire, Yale University, and Alkahest, alongside repeated funding to The Institute for Neurodegenerative Disorders over multiple years. That mix points to a foundation financing discovery, translational work, and the infrastructure needed to move studies forward. The foundation funds basic research, biomarker and diagnostic work, therapeutic development, clinical trial support, participant recruitment, patient engagement, and data and biospecimen resources. Its portfolio includes named programs for Parkinson’s disease progression markers, target validation, therapeutic pipeline work, and collaborative research networks. The active grants also show support for clinician training through The Edmond J. Safra Fellowship in Movement Disorders and for community health worker training tied to brain health and Parkinson’s research engagement. Leadership is centered on CEO Deborah W. Brooks, and the organization reports annual grants far above $400 million. The recent grants list includes universities, research institutes, biotech companies, and disease-focused nonprofits, which suggests a grantmaker that operates across the research ecosystem rather than through a single channel.
Biomarker and diagnostic research is a clear thread. The PPMI Biofluid Biomarkers Program seeks collaborators with analytically validated biomarker assays to use in existing PPMI biosamples, and the foundation also gave $6,368,000 to Psomagen Inc for Parkinson's research. Therapeutic development is another major area. Through the Parkinson's Disease Therapeutics Pipeline Program, the foundation supports pre-clinical and clinical testing of approaches that address unmet needs in Parkinson’s disease. A related recent grant went to Libra Therapeutics for Parkinson's research. The foundation also funds clinical and patient-facing work. It awarded $200,000 for an Access Advocate for Clinical Research Participation project aimed at improving inclusive enrollment and retention, and it supports a fellowship in movement disorders for clinician-researchers. Community engagement appears in the remote training modules project for community health workers focused on brain health and Parkinson's research engagement.
$240.2M
$439M
$505.3M
$452.5M
Most grants fall between $120K and $977K, with a median of $321K.
25th Percentile
$120K
Median
$321K
75th Percentile
$977K
About 10% of grants go to recipients in CA.
DEBORAH W BROOKS CEO
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
Typical grant size sits at a p25 of $120,364, a median of $321,435, and a p75 of $977,392, but the recent grants list also shows several multi-million-dollar awards. The foundation is a regular funder and makes grants nationally, with 100% of listed grants going to US recipients. Its recent records show repeat awards to the same organizations across multiple years, including The Institute for Neurodegenerative Disorders and Greenphire, which points to ongoing relationships rather than one-off support. It also accepts unsolicited applications for several active programs, including biomarker, therapeutic, and collaborative research tracks.
The grant map is national, with recipients in 100% of listed grants located in the United States. Massachusetts is the top state by grant count, and the recent grants list includes several Cambridge and Boston-area recipients such as Harvard University and Merck Sharp & Dohme LLC. New Haven, Connecticut, also appears repeatedly through Yale University and The Institute for Neurodegenerative Disorders. Other recurring recipient hubs include San Francisco and South San Francisco, plus Bloomington, Indiana, and King of Prussia, Pennsylvania.
Its stated focus areas include Parkinson's disease basic research, biomarkers and diagnostics, therapeutic development, clinical trial support and participant recruitment, patient engagement and education, and data and biospecimen resources. The active programs also extend into target validation, clinician training, and community health worker training tied to Parkinson's research engagement.
The typical grant size distribution is $120,364 at the 25th percentile, $321,435 at the median, and $977,392 at the 75th percentile. The recent grants list also includes much larger awards, including several in the multi-million-dollar range.
No. The recent grants list shows repeated support to the same organizations across multiple years, including The Institute for Neurodegenerative Disorders and Greenphire. That suggests the foundation uses ongoing relationships as well as individual project grants.
Yes. Several active programs accept unsolicited applications, including the PPMI Biofluid Biomarkers Program, the Parkinson's Disease Therapeutics Pipeline Program, Targets to Therapies: Aggregation and Synuclein Biology Target Validation, and the ASAP Collaborative Research Network 2025 Technical Track.
Recipients include universities, research institutes, biotech and health technology companies, and disease-focused nonprofits. Recent grants went to organizations such as Yale University, Northwestern University, Greenphire, Alkahest, and the Parkinson's Foundation.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Current and upcoming funding from Michael J Fox Foundation for Parkinson'S Research that your nonprofit may be able to apply for.
Who can apply: Early career investigator-led Alzheimer’s, Parkinson’s and related research projects disrupted by changes in federal research funding.
Deadline: Rolling Deadline
Who can apply: Projects aligned with therapeutic development milestones and evidence generation needs.
Deadline: Rolling Deadline
Track these deadlines, get reminders, and see how well your nonprofit fits — free with a Kindora account.
Create a free accountDeadlines and eligibility are summarized from public sources and may change — always confirm the details on the funder's official application page before applying.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| PARKINSON'S FOUNDATION | NEW YORK, NY | $21,012,000 | 2025 | PARKINSON'S RESEARCH |
| GREENPHIRE | KING OF PRUSSIA, PA | $18,613,259 | 2025 | PARKINSON'S RESEARCH |
| YALE UNIVERSITY | NEW HAVEN, CT | $18,387,153 | 2025 | PARKINSON'S RESEARCH |
| ALKAHEST | SAN CARLOS, CA | $18,138,879 | 2025 | PARKINSON'S RESEARCH |
| XINGIMAGING LLC | WOODBRIDGE, CT | $12,650,299 | 2025 | PARKINSON'S RESEARCH |
| INDIANA UNIVERSITY | BLOOMINGTON, IN | $11,933,381 | 2025 | PARKINSON'S RESEARCH |
| THE INSTITUTE FOR NEURODEGENERATIVE DISORDERS | NEW HAVEN, CT | $9,959,926 | 2025 | PARKINSON'S RESEARCH |
| NORTHWESTERN UNIVERSITY | EVANSTON, IL | $7,485,471 | 2025 | PARKINSON'S RESEARCH |
| PSOMAGEN INC | ROCKVILLE, MD | $6,368,000 | 2025 | PARKINSON'S RESEARCH |
| NICO THERAPEUTICS | SOUTH SAN FRANCISCO, CA | $6,248,349 | 2025 | PARKINSON'S RESEARCH |
| LIBRA THERAPEUTICS | SAN DIEGO, CA | $4,978,912 | 2025 | PARKINSON'S RESEARCH |
| UNIVERSITY OF PITTSBURGH | PITTSBURGH, PA | $4,664,483 | 2025 | PARKINSON'S RESEARCH |
| CND LIFE SCIENCES | PHOENIX, AZ | $4,054,095 | 2025 | PARKINSON'S RESEARCH |
| GE HEALTHCARE | PRINCETON, NJ | $3,991,055 | 2025 | PARKINSON'S RESEARCH |
| UNIVERSITY OF IOWA | IOWA CITY, IA | $3,811,739 | 2025 | PARKINSON'S RESEARCH |
| HARVARD UNIVERSITY | CAMBRIDGE, MA | $3,592,873 | 2025 | PARKINSON'S RESEARCH |
| EMORY UNIVERSITY | ATLANTA, GA | $3,410,603 | 2025 | PARKINSON'S RESEARCH |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | SAN FRANCISCO, CA | $3,404,237 | 2025 | PARKINSON'S RESEARCH |
| UNIVERSITY OF CALIFORNIA BERKELEY | BERKELEY, CA | $3,279,015 | 2025 | PARKINSON'S RESEARCH |
| MONTARA THERAPEUTICS INC | SAN FRANCISCO, CA | $3,266,335 | 2025 | PARKINSON'S RESEARCH |
| DUKE UNIVERSITY | DURHAM, NC | $3,146,186 | 2025 | PARKINSON'S RESEARCH |
| AMPRION | SAN FRANCISCO, CA | $2,800,000 | 2025 | PARKINSON'S RESEARCH |
| SCHRODINGER | NEW YORK, NY | $2,756,688 | 2025 | PARKINSON'S RESEARCH |
| HILLHURST BIOPHARMACEUTICALS INC | MONTROSE, CA | $1,958,502 | 2025 | PARKINSON'S RESEARCH |
| FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH | NORTH BETHESDA, MD | $1,901,404 | 2025 | PARKINSON'S RESEARCH |
| EICOSIS | DAVIS, CA | $1,867,317 | 2025 | PARKINSON'S RESEARCH |
| CRITICAL PATH INSTITUTE | TUCSON, AZ | $1,813,760 | 2025 | PARKINSON'S RESEARCH |
| ABBVIE INC | NORTH CHICAGO, IL | $1,778,698 | 2025 | PARKINSON'S RESEARCH |
| INFLAMMANOVA RX LLC | BIRMINGHAM, AL | $1,740,000 | 2025 | PARKINSON'S RESEARCH |
| EVIDATION HEALTH | SAN MATEO, CA | $1,621,918 | 2025 | PARKINSON'S RESEARCH |
| NEUMORA THERAPEUTICS | WATERTOWN, MA | $1,601,873 | 2025 | PARKINSON'S RESEARCH |
| C2N DIAGNOSTICS LLC | ST LOUIS, MO | $1,583,780 | 2025 | PARKINSON'S RESEARCH |
| STANFORD UNIVERSITY | STANFORD, CA | $1,559,701 | 2025 | PARKINSON'S RESEARCH |
| BRIGHAM & WOMEN'S HOSPITAL INC | BOSTON, MA | $1,512,159 | 2025 | PARKINSON'S RESEARCH |
| SANDBOX AQ | PALO ALTO, CA | $1,500,000 | 2025 | PARKINSON'S RESEARCH |
| WASHINGTON UNIVERSITY SCHOOL OF MEDICINE | ST LOUIS, MO | $1,473,355 | 2025 | PARKINSON'S RESEARCH |
| LONGEVITY BIOTECH | PHILADELPHIA, PA | $1,450,275 | 2025 | PARKINSON'S RESEARCH |
| SIBEL HEALTH | NILES, IL | $1,331,759 | 2025 | PARKINSON'S RESEARCH |
| CLEVELAND CLINIC | CLEVELAND, OH | $1,319,471 | 2025 | PARKINSON'S RESEARCH |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | SAN FRANCISCO, CA | $1,268,507 | 2025 | PARKINSON'S RESEARCH |
| OSSIANIX INC | BRYN MAWR, PA | $1,233,799 | 2025 | PARKINSON'S RESEARCH |
| ALECTOR | SOUTH SAN FRANCISCO, CA | $1,137,488 | 2025 | PARKINSON'S RESEARCH |
| BEXION PHARMACEUTICALS | COVINGTON, KY | $1,110,438 | 2025 | PARKINSON'S RESEARCH |
| EOS THERAPIES INC | SAN DIEGO, CA | $1,100,000 | 2025 | PARKINSON'S RESEARCH |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | BIRMINGHAM, AL | $1,085,483 | 2025 | PARKINSON'S RESEARCH |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES | LOS ANGELES, CA | $1,028,441 | 2025 | PARKINSON'S RESEARCH |
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | BOSTON, MA | $979,459 | 2025 | PARKINSON'S RESEARCH |
| OCTAVE BIOSCIENCE INC | MENLO PARK, CA | $958,786 | 2025 | PARKINSON'S RESEARCH |
| VERILY LIFE SCIENCES | SAN FRANCISCO, CA | $954,539 | 2025 | PARKINSON'S RESEARCH |
| LOUISIANA STATE UNIVERSITY | SHREVEPORT, LA | $896,409 | 2025 | PARKINSON'S RESEARCH |
GREENPHIRE
$18,613,259PARKINSON'S RESEARCH
ALKAHEST
$18,138,879PARKINSON'S RESEARCH
XINGIMAGING LLC
$12,650,299PARKINSON'S RESEARCH
INDIANA UNIVERSITY
$11,933,381PARKINSON'S RESEARCH
THE INSTITUTE FOR NEURODEGENERATIVE DISORDERS
$9,959,926PARKINSON'S RESEARCH
PSOMAGEN INC
$6,368,000PARKINSON'S RESEARCH
NICO THERAPEUTICS
$6,248,349PARKINSON'S RESEARCH
LIBRA THERAPEUTICS
$4,978,912PARKINSON'S RESEARCH
CND LIFE SCIENCES
$4,054,095PARKINSON'S RESEARCH
GE HEALTHCARE
$3,991,055PARKINSON'S RESEARCH
UNIVERSITY OF IOWA
$3,811,739PARKINSON'S RESEARCH
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
$3,404,237PARKINSON'S RESEARCH
UNIVERSITY OF CALIFORNIA BERKELEY
$3,279,015PARKINSON'S RESEARCH
MONTARA THERAPEUTICS INC
$3,266,335PARKINSON'S RESEARCH
AMPRION
$2,800,000PARKINSON'S RESEARCH
SCHRODINGER
$2,756,688PARKINSON'S RESEARCH
HILLHURST BIOPHARMACEUTICALS INC
$1,958,502PARKINSON'S RESEARCH
PARKINSON'S RESEARCH
EICOSIS
$1,867,317PARKINSON'S RESEARCH
ABBVIE INC
$1,778,698PARKINSON'S RESEARCH
INFLAMMANOVA RX LLC
$1,740,000PARKINSON'S RESEARCH
EVIDATION HEALTH
$1,621,918PARKINSON'S RESEARCH
NEUMORA THERAPEUTICS
$1,601,873PARKINSON'S RESEARCH
C2N DIAGNOSTICS LLC
$1,583,780PARKINSON'S RESEARCH
BRIGHAM & WOMEN'S HOSPITAL INC
$1,512,159PARKINSON'S RESEARCH
SANDBOX AQ
$1,500,000PARKINSON'S RESEARCH
LONGEVITY BIOTECH
$1,450,275PARKINSON'S RESEARCH
SIBEL HEALTH
$1,331,759PARKINSON'S RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO
$1,268,507PARKINSON'S RESEARCH
OSSIANIX INC
$1,233,799PARKINSON'S RESEARCH
ALECTOR
$1,137,488PARKINSON'S RESEARCH
BEXION PHARMACEUTICALS
$1,110,438PARKINSON'S RESEARCH
EOS THERAPIES INC
$1,100,000PARKINSON'S RESEARCH
UNIVERSITY OF ALABAMA AT BIRMINGHAM
$1,085,483PARKINSON'S RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
$1,028,441PARKINSON'S RESEARCH
OCTAVE BIOSCIENCE INC
$958,786PARKINSON'S RESEARCH
VERILY LIFE SCIENCES
$954,539PARKINSON'S RESEARCH
LOUISIANA STATE UNIVERSITY
$896,409PARKINSON'S RESEARCH